Portfolio

Velcera, Inc.

Developed pet medication for the companion animal health industry, including the leading OTC flea and tick franchise, PetArmor®


Velcera was a leading companion animal health product company committed to providing consumers with best-in-class pet health products that contained the same active ingredients as branded veterinary products, but at a lower cost. The company’s products offered consumers the benefits of cost savings and convenient access through mass retail channels, while still providing high-quality care for their pets. Velcera’s flagship PetArmor® brand was supported by several pipeline product candidates in both the flea and tick and health and wellness categories that continue to bring additional products to the consumer.

Transaction Summary

  • Essex Woodlands identified the animal health sector, with its strong growth and limited reimbursement risk, as an attractive area for investment and served as the lead growth equity investor in the company’s 2010 capital raise.
  • In February 2013, Velcera was sold to Perrigo for $160 million in cash.

Related News

  • FidoPharm and the ASPCA Team Up to Launch New PetArmor Over-the-Counter Flea and Tick Treatment
  • “Essex Woodlands led our capital round, and provided so much more than the growth equity capital Velcera required. While our board had a strong chairman, the director from Essex provided effective informal leadership throughout our building stage through his knowledge, sound business judgment and professional and effective communication style. All new companies who break the status quo run into difficulties and turbulent times, and our company certainly faced our fair share of these adversities. As the CEO, I can honestly say “Thank goodness!” for the steady, calming influence of Essex on our board team. They stayed positive, looked for solutions and kept all eyes focused on the future ahead. As a result, the Essex transaction expertise proved to be invaluable as we negotiated a very successful exit.”

    Dennis Steadman

    Chief Executive Officer